HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings
Revenue increased 307% and 87%, respectively, compared to the three and nine month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz. , Nov. 07, 2017 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc.
- Category:
- Press Releases